Fallbericht
Post-COVID-19 complement-mediated TMA: A case report
Clinical Nephrology · 2024
DOI: 10.5414/cn111217 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Jan A Jochims und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Thrombotic Microangiopathies.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
COVID-19Thrombotic MicroangiopathiesHumansMaleAgedSARS-CoV-2GlucocorticoidsPlasma ExchangeAntibodies, Monoclonal, HumanizedAcute Kidney InjuryComplement Inactivating AgentsRenal Dialysis
Substanzen
GlucocorticoidsAntibodies, Monoclonal, HumanizedComplement Inactivating Agentseculizumab
Zitieren
APA
Jochims, J. A., Yazdani, B., Krüger, B., Popovic, Z. V., & Krämer, B. K. (2024). Post-COVID-19 complement-mediated TMA: A case report. Clinical Nephrology. https://doi.org/10.5414/cn111217
Vancouver
Jochims JA, Yazdani B, Krüger B, Popovic ZV, Krämer BK. Post-COVID-19 complement-mediated TMA: A case report. Clinical Nephrology. 2024. doi:10.5414/cn111217
BibTeX
@article{Jochims2024,
author = {Jochims, Jan A and Yazdani, Babak and Krüger, Bernd and Popovic, Zoran V and Krämer, Bernhard K},
title = {Post-COVID-19 complement-mediated TMA: A case report},
journal = {Clinical Nephrology},
year = {2024},
doi = {10.5414/cn111217}
}
EUVIMED